A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema
Clinical trial NCT01315275 · COMPLETED
Trial details
- NCT number
- NCT01315275
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-08-01
- Enrollment
- 394
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.